CorMedix Inc.CRMDNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
5.14
↑ 179% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-6.52
Historical baseline
PeriodValueYoY Change
20255.14+119.3%
2024-26.60-543.9%
2023-4.13+27.6%
2022-5.70+6.0%
2021-6.07+37.0%
2020-9.63+10.0%
2019-10.70-149.8%
2018-4.28-412.8%
2017-0.84+64.6%
2016-2.36-